Adenoma hipofisario asociado a feocromocitoma/paraganglioma: una nueva forma de neoplasia endocrina múltiple
Fernando Pérez-Sánz(Instituto Murciano de Investigación Biosanitaria), Carles Villabona Artero(Bellvitge University Hospital), Pedro Iglesias(Hospital Universitario Puerta de Hierro Majadahonda), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Arturo Lisbona Gil(Hospital Central de la Defensa Gómez Ulla)
Cited by 14
Related Papers
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
|Journal of Hypertension|2020|406
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
|Human Molecular Genetics|2013|394
An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes
|Hormone and Metabolic Research|2012|287
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
|The Lancet Oncology|2010|274